Highly penetrant hereditary cancer syndromes

被引:238
作者
Nagy, R
Sweet, K
Eng, C
机构
[1] Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43221 USA
[2] Ohio State Univ, Human Genet Program, Ctr Comprehens Canc, Div Human Genet,Dept Internal Med, Columbus, OH 43221 USA
关键词
inherited cancer susceptibility; familial cancer syndromes; breast cancer; colon cancer; endocrine neoplasia;
D O I
10.1038/sj.onc.1207714
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Approximately 5-10% of all cancers are inherited, the majority in an autosomal dominant manner with incomplete penetrance. While this is a small fraction of the overall cancer burden worldwide, the molecular genetic discoveries that have resulted from the study of families with heritable cancer have not only changed the way these families are counselled and managed, but have shed light on molecular regulatory pathways important in sporadic tumour development as well. In this review, we consider 10 of the more highly penetrant cancer syndromes, with emphasis on those predisposing to breast, colon, and/or endocrine neoplasia. We discuss the prevalence, penetrance, and tumour spectrum associated with these syndromes, as well as their underlying genetic defects.
引用
收藏
页码:6445 / 6470
页数:26
相关论文
共 367 条
[1]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]  
AALTONEN LA, 2000, PATHOLOGY GENETICS T, P74
[3]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[4]  
2-C
[5]   Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors [J].
Al-Tassan, N ;
Chmiel, NH ;
Maynard, J ;
Fleming, N ;
Livingston, AL ;
Williams, GT ;
Hodges, AK ;
Davies, DR ;
David, SS ;
Sampson, JR ;
Cheadle, JR .
NATURE GENETICS, 2002, 30 (02) :227-232
[6]  
Anderson TI, 1996, AM J HUM GENET, V59, P486
[7]  
[Anonymous], 1995, American Cancer Society Textbook of Clincal Oncology
[8]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[9]   BRCA1-associated growth arrest is RB-dependent [J].
Aprelikova, ON ;
Fang, BS ;
Meissner, EG ;
Cotter, S ;
Campbell, M ;
Kuthiala, A ;
Bessho, M ;
Jensen, RA ;
Liu, ET .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :11866-11871
[10]   Regulation of p53 stability [J].
Ashcroft, M ;
Vousden, KH .
ONCOGENE, 1999, 18 (53) :7637-7643